Research on situation and countermeasure of Erigeron breviscapus plant production.
- Author:
Wei ZHANG
1
;
Sheng-Chao YANG
;
Guang-Hui ZHANG
;
Bao SU
Author Information
1. Yunnan Research Center on Good Agriculture Practice for Dominant Chinese Medicinal Materials, Yunnan Agriculture University, Kunming 650201, China. zw_biology2@126.com
- Publication Type:Journal Article
- MeSH:
Drug Industry;
Erigeron;
growth & development;
Medicine, Chinese Traditional;
Plants, Medicinal;
growth & development
- From:
China Journal of Chinese Materia Medica
2013;38(14):2227-2230
- CountryChina
- Language:Chinese
-
Abstract:
For more than ten years, Erigeron breviscapus has been used for the treatment of cardiovascular and cerebrovascular diseases, it experienced the procedure from wild species to the cultivars, and the quality of drug was rapidly improved. In order to further promote the development of E. breviscapus planting industry, this paper analyzes the development status and existing problems of E. breviscapus planting. Some measures would be come forward, such as strengthen the government's policy support and industrial regulate, accelerate the industry standard and technological innovation, expand brand effect of E. breviscapus of Yunnan, so that the industry has the health and sustainable development.
